Results From a Prospective, Open-Label, Phase II Trial of Bendamustine in Refractory or Relapsed T-Cell Lymphomas: The BENTLY Trial.

Details

Language :

English

ISSN :

0732183X

Volume :

31

Issue :

1

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

84509094

Full Text :

https://doi.org/10.1200/JCO.2012.43.7285